Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort studyKurvi Patwala, Anouk Dev, Eldho Paul et al.|Hepatology International|2022Cited by 15
FRI-053 Wide variations in proton pump inhibitor use in hospitalized patients with cirrhosis in a worldwide cohort shows little impact on clinically significant outcomesJasmohan S. Bajaj, Carlos Benítez, Patrick S. Kamath et al.|Journal of Hepatology|2024Cited by 0